Market Watch
Search documents
These Big Tech stocks look to grab the biggest AI market share in 2024
Market Watch· 2024-01-08 21:50
It’s hard to imagine that the chip and technology sector could repeat the stunning year it had in 2023, but financial and technology analyst groups both are nearly universal in agreement that 2024 will be just that. Fueled by the need for more computing horsepower than ever before, including the rise of AI, chip companies will likely see 2024 as another strong year, with nuances between the levels of success.Let’s start with a look at some of the critical players in the data center and IT infrastructure mar ...
Bill Ackman opened a wormhole of plagiarism allegations at Harvard — now his wife has been sucked in
Market Watch· 2024-01-08 20:25
Billionaire hedge fund manager Bill Ackman led the charge to push out Harvard’s president Claudine Gay amid charges of plagiarism. But now the recriminations have boomeranged back on him, with reports that his academic wife may have committed plagiarism in her dissertation.The reports in Business Insider late last week have triggered off a dizzying array of allegations from Ackman, who insists his family should be off-limits to scrutiny, which has pushed the news site’s publisher, Axel Springer SE, into say ...
Apple stock looks expensive vs. the rest of the ‘Magnificent Seven'
Market Watch· 2024-01-08 19:19
Apple Inc.’s stock had a very good run in 2023, but it is starting 2024 with looming issues that make it look expensive for investors.To begin, Apple AAPL, +2.02% has morphed into a slow-growth company, failing to increase year-over-year revenue in each of its past four reported quarters. The company is heavily reliant on its iPhone business, but innovation on the device has stagnated, making consumers less likely to upgrade their devices in a rockier economic climate. All the while, Apple shares carry a hi ...
Nvidia dives deeper into AI drug development with Amgen, Recursion partnerships
Market Watch· 2024-01-08 18:00
Nvidia Corp. NVDA, +4.83% is doubling down on artificial-intelligence-powered drug discovery and development, announcing expanded partnerships Monday with Amgen Inc. AMGN, +1.35% and Recursion Pharmaceuticals Inc. RXRX, +3.65%. Amgen subsidiary deCODE Genetics is building out an Nvidia supercomputer to create genomics “foundation models” — models trained on massive datasets to tackle a variety of jobs — to fuel drug discovery, Nvidia said Monday at the JPMorgan Chase & Co. JPM, -1.50% healthcare conference ...
Bank of America to take $1.6 billion noncash charge as it transitions away from BSBY index for lending
Market Watch· 2024-01-08 17:41
Bank of America Corp. on Monday said it would take a noncash pretax charge of about $1.6 billion in its fourth-quarter report related to the global transition away from an index used to replace the London interbank offered rate, or Libor.Bank of America BAC, -1.87% said the $1.6 billion net impact is expected to be added back into its interest income in subsequent periods, largely through 2026, according to a filing.The accounting adjustment follows the discontinuation of the Bloomberg Short-Term Bank Yield ...
Tiger Woods and Nike part ways after 27 years
Market Watch· 2024-01-08 17:26
After 27 years of wearing Nike’s NKE, +0.40% swoosh during golf tournaments, Tiger Woods will no longer be sponsored by the company. “Over 27 years ago, I was fortunate to start a partnership with one of the most iconic brands in the world,” Woods said on X, formerly Twitter. “The days since have been filled with so many amazing moments and memories, if I started naming them, I could go on forever. Phil Knight’s passion and vision brought this Nike and Nike Golf partnership together and I want to persona ...
The surprising stocks that are top picks for market-watchers
Market Watch· 2024-01-08 16:07
I bet you can’t guess which stock is most popular right now among monitored investment newsletters. It’s not Apple AAPL, the Wall Street perennial favorite that nearly doubled the market’s total return in 2023, gaining 49.0% to the S&P 500’s 26.3%. Nor is it Nvidia NVDA, whose stock gained 239% in 2023 as Wall Street became enamored of AI. Instead,... Master your money. Subscribe to MarketWatch. Get this article and all of MarketWatch. Access from any device. Anywhere. Anytime. Subscribe Now Al ...
Apple's stock set to snap losing streak, as Vision Pro mixed-reality headsets to be available in early February
Market Watch· 2024-01-08 14:17
Apple Inc. AAPL, -0.40% announced Monday that pre-orders for its Apple Vision Pro mixed-reality headset will begin on Jan. 19. The headsets will be available at all U.S. stores, and the online store, beginning Feb. 2. Apple’s stock rose 0.6% in premarket trading, which puts it on track to book its first gain of 2024, and snap a five-session losing streak. The timing of the availability of the headsets was basically expected, as Bloomberg had reported in mid-December that they would be launched by February. ...
3M to freeze U.S. pensions for non-union employees
Market Watch· 2024-01-08 13:09
Shares of 3M Co. MMM, +0.39% slipped 0.1% in premarket trading after the the consumer, industrial and health care-products company said it will freeze its U.S. pension plan for non-union employees, as of Dec. 31, 2028. The company said people who are currently receiving pension payments are not impacted by this freeze, which 3M said has been in the works for “many” years. “This is an important decision for 3M as it helps to set up both companies for future success. This was also a difficult decision becaus ...
Axonic's stock soars after cash buyout deal with Boston Scientific valued at $3.7 billion
Market Watch· 2024-01-08 12:10
Shares of Axonics Inc. AXNX, -0.84% soared 19.2% toward a 13-month high in premarket trading Monday, after the medical technology company focused on treating urinary and bowel dysfunction announced an agreement to be acquired by Boston Scientific Corp. BSX, -0.02% in a cash deal with an equity value of about $3.7 billion. Under terms of deal, Boston Scientific will pay $71 for each Axonics shares outstanding, which represents a 23.3% premium to Friday’s closing price of $57.57. Boston Scientific’s stock ta ...